Abstract
In summary, advances in our understanding of basic human NK cell biology, including NK cell differentiation and the mechanisms of NK cell target recognition have led to the initial design of rational therapeutic strategies for the treatment of leukemia. Further investigation of the biology of these potent immune effectors will likely result in additional novel immune-based strategies for the treatment of cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 736-737 |
| Number of pages | 2 |
| Journal | Leukemia |
| Volume | 16 |
| Issue number | 4 |
| DOIs | |
| State | Published - 2002 |